  | Wenric, S., El Guendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., Olivier, F., Jossa, V., JERUSALEM, G., JOSSE, C., & BOURS, V. (May 2017). Transcriptome wide analysis of natural antisense transcripts shows potential role in breast cancer [Poster presentation]. 50th meeting of the European Society of Human Genetics, Copenhagen, Denmark. |
 | Wenric, S., ElGuendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., OLIVIER, F., Jossa, V., Jerusalem, G., JOSSE, C., & Bours, V. (2017). Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer. Scientific Reports, 7 (1), 17452. doi:10.1038/s41598-017-17811-2  Peer Reviewed verified by ORBi |
 | Boukerroucha, M. (2016). Evaluation des paramètres moléculaires BRCA1 et des micro-ARN comme facteurs pronostiques pour des cancers du sein triples négatifs [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315267 |
 | Freres, P.* , Wenric, S.* , BOUKERROUCHA, M., Fasquelle, C., Thiry, J., Bovy, N., Struman, I., Geurts, P., COLLIGNON, J., SCHROEDER, H., KRIDELKA, F., LIFRANGE, E., Jossa, V., Bours, V.* , Josse, C.* , & JERUSALEM, G.*. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. doi:10.18632/oncotarget.6786 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Boukerroucha, M., Josse, C., SEGERS, K., El Guendi, S., FRERES, P., JERUSALEM, G., & Bours, V. (26 March 2015). BRCA1 germline mutation and glioblastoma development: report of cases. BMC Cancer, 15, 181. doi:10.1186/s12885-015-1205-1 Peer Reviewed verified by ORBi |
 | Boukerroucha, M., Josse, C., El Guendi, S., Boujemla, B., Freres, P., Marée, R., Wenric, S., SEGERS, K., COLLIGNON, J., Jerusalem, G., & Bours, V. (2015). Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers. BMC Cancer, 15 (1), 755. doi:10.1186/s12885-015-1740-9 Peer Reviewed verified by ORBi |
 | Wenric, S., JOSSE, C., Fasquelle, C., Poulet, C., Sticca, T., Boukerroucha, M., JERUSALEM, G., & Bours, V. (15 March 2013). Exome sequencing of tumors: relevance in copy-number alteration (CNA) analysis and fixed tissue samples [Poster presentation]. 13th Annual Meeting of the Belgian Society of Human Genetics, Bruxelles, Belgium. |
  | COLLIGNON, J., Struman, I., Tabruyn, S., Josse, C., Boukerroucha, M., JERUSALEM, G., & BOURS, V. (2011). Aspects moléculaires du cancer du sein triple négatif et les implications thérapeutiques. Revue Médicale de Liège, 66 (5-6), 393-396. Peer reviewed |
 | Marquez, L., Shen, C., Cleynen, I., De Hertogh, G., Van Steen, K., Machiels, K., Perrier, C., Ballet, V., Organe, S., Boukerroucha, M., Henckaerts, L., Galicia, G., Rutgeerts, P., Ceuppens, J. L., & Vermeire, S. (2011). Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. Gut, 61 (4), 528-534. doi:10.1136/gut.2011.240978 Peer Reviewed verified by ORBi |
 | Schnitzler, F., Fidder, H., Boukerroucha, M., Ballet, V., Noman, M., Van Assche, G., Spitz, B., Hoffman, I., Van Steen, K., Vermeire, S., & Rutgeerts, P. (2011). Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflammatory Bowel Diseases, 17 (9), 1846-1854. doi:10.1002/ibd.21583 Peer Reviewed verified by ORBi |